The Effect of Myofascial Release Technique on the Treatment of Primary Dysmenorrhea in Psoas Muscle
The Effect of Myofascial Relaxation Technique on the Treatment of Primary Dysmenorrhea in Psoas Muscle
1 other identifier
interventional
38
1 country
1
Brief Summary
Dysmenorrhea is a series of pathological symptoms associated with menstruation that interfere with daily activities such as abdominal cramps and pain in the menstrual period. General symptoms such as nausea, vomiting, lumbago, diarrhea and headache are also common. Primary dysmenorrhea refers to menstrual pain that does not depend on the underlying pathology. The kidneys act on the fascia of the psoas muscle. If the psoas muscle does not shorten and grow sufficiently, the kidneys may not move for a certain period of time and may experience ptosis. This causes venous ponding and may cause varicocele in men and primary dysmenorrhea in women. Techniques to be applied directly to the fascia of the psoas muscle can reduce symptoms of dysmenorrhea in women. In the literature review, no studies investigating the effectiveness of a treatment applied directly and only on the psoas muscle on primary dysmenorrhea were not found. This study can set an example for future studies. In our study, myofascial relaxation technique will be applied in women with primary dysmenorrhoea and its effect on pain will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 3, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2020
CompletedApril 21, 2020
February 1, 2020
2 months
February 3, 2020
April 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Visual analog scale
Pain intensity will be questioned by scale.For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[100-mm scale\]) . To avoid clustering of scores around a preferred numeric value, numbers or verbal descriptors at intermediate points are not recommended
5 seconds
Study Arms (2)
Study Group
EXPERIMENTALMyofascial relaxation technique
Control group
NO INTERVENTIONInterventions
* Before the intervention, the number of days of the last menstrual cycle of all participants, the number of painful days throughout the cycle, pain intensity values according to the Visual Analogue Scale will be recorded, and the scores will be recorded in the participants. * Technique of direct relaxation of fascia of both psoas muscles to the participants in the myofascial relaxation group since the end of the last cycle, 90-120 sec. It will be applied by the physiotherapist twice a week.
Eligibility Criteria
You may qualify if:
- The age range is 18-30,
- Intense pain compared to visual analog scale in the lower region of the abdomen during or just before the menstruation period (\> 4),
- No pregnancy history,
- Not using drugs for dysmenorrhea symptoms
You may not qualify if:
- Not agreeing to participate in the study,
- Endometriosis, ovarian cyst, uterine fibroid, congenital malformation or pelvic inflammation,
- Having a diagnosis of secondary dysmenorrhea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Esra Pehli̇van
Istanbul, Üsküdar, 34668, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Tülay Ülkü Sevim
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 3, 2020
First Posted
February 5, 2020
Study Start
February 10, 2020
Primary Completion
April 3, 2020
Study Completion
April 20, 2020
Last Updated
April 21, 2020
Record last verified: 2020-02